Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Annick DesJardins
Duke University, Department: Neurosurgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Istari Oncology
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Desjardins has equity in Istari which have licensed intellectual property used in project 3 of this grant. She will be the PI for the clinical trials proposed in Projects 1 and 2, which are not related to her company or IP, and will be responsible for neuro-oncological care of all patients enrolled on the protocols.
Experimental Therapy for Brain Tumors
PROJECT NARRATIVE ? Overall Malignant primary brain tumors, like glioblastoma (GBM), are the most frequent cause of cancer death in children and young adults and account for more deaths than cancer of the kidney or melanoma. Moreover, current therapy is incapacitating and limited by non-specific toxicity to systemic tissue or surrounding eloquent brain. The research proposed in this application focuses on the development of novel immunotherapeutic platforms against GBM, investigates and integrates the mechanisms behind the immune activity of these platforms, and takes basic science and recent clinical findings to the next level of clinical translation.
Filed on March 14, 2019.
Tell us what you know about Annick DesJardins's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Annick DesJardins”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Annick DesJardins | Duke University | Conflict of Interest | None | Value cannot be readily determined |
| Annick DesJardins | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| Annick DesJardins | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| Annick DesJardins | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| Annick DesJardins | Duke University | Conflict of Interest | None - unlicensed IP | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.